Carregant...
5-ALA-guided resection of glioblastoma: a single-centre, retrospective analysis of progression pattern and survival
INTRODUCTION: The EORTC-NCIC trial in glioblastoma showed a median overall survival (OS) rate of 14.6 months following resection and chemoradiotherapy. This poor prognosis is attributed to early invasion and almost inevitable progression with failure to achieve local control. However, improvement in...
Guardat en:
| Publicat a: | Neuro Oncol |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5791633/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox238.085 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|